Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Changqing Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3396-7248; OpenAlex author ID A5010613321. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 4

  1. Simultaneous Overexpression of miR-126 and miR-34a Induces a Superior Antitumor Efficacy in Pancreatic Adenocarcinoma [Retraction]. Last author DOI 10.2147/ott.s252412↗
  2. Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma. Last author DOI 10.2147/ott.s149632↗
  3. Viral therapy for pancreatic cancer: tackle the bad guys with poison. Co-author DOI 10.1016/j.canlet.2013.01.035↗
  4. CEA promoter-regulated oncolytic adenovirus-mediated Hsp70 expression in immune gene therapy for pancreatic cancer. Co-author DOI 10.1016/j.canlet.2012.01.009↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shu-De Feng · 2 shared papers, 2017–2020 · strength 0.20
  2. Can Xu · 2 shared papers, 2012–2013 · strength 0.08
  3. Zhao‐Shen Li · 2 shared papers, 2012–2013 · strength 0.08
  4. Yunliang Sun · 1 shared paper, 2012 · strength 0.03
  5. Yan Yan · 1 shared paper, 2012 · strength 0.03
  6. Maoling Zhu · 1 shared paper, 2012 · strength 0.03
  7. Lei Chen · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.